{"id":"https://openalex.org/W2005237889","doi":"https://doi.org/10.1093/infdis/150.1.7","title":"The Effects of Acyclovir on Antibody Response to Herpes Simplex Virus in Primary Genital Herpetic Infections","display_name":"The Effects of Acyclovir on Antibody Response to Herpes Simplex Virus in Primary Genital Herpetic Infections","alternate_titles":[],"publication_year":1984,"publication_date":"1984-07-01","ids":{"openalex":"https://openalex.org/W2005237889","doi":"https://doi.org/10.1093/infdis/150.1.7","mag":"2005237889","pmid":"https://pubmed.ncbi.nlm.nih.gov/6086772"},"language":"en","primary_location":{"id":"doi:10.1093/infdis/150.1.7","doi":"https://doi.org/10.1093/infdis/150.1.7","is_oa":false,"landing_page_url":"https://doi.org/10.1093/infdis/150.1.7","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005237889"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090332369","display_name":"David I. Bernstein","orcid":"https://orcid.org/0000-0002-0100-1991","observed_orcids":["https://orcid.org/0000-0002-0100-1991"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. I. Bernstein","raw_affiliation_strings":["From the Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. A. Lovett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. A. Lovett","raw_affiliation_strings":["From the Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008280183","display_name":"Yvonne J. Bryson","orcid":"https://orcid.org/0000-0003-1589-269X","observed_orcids":["https://orcid.org/0000-0003-1589-269X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. J. Bryson","raw_affiliation_strings":["From the Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":6.4066,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.9669655,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"150","issue":"1","first_page":"7","last_page":"13"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11112","display_name":"Viral Infections and Immunology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acyclovir","display_name":"acyclovir","score":1.0},{"id":"https://openalex.org/keywords/herpes-simplex-virus","display_name":"herpes simplex virus","score":0.8840000033378601},{"id":"https://openalex.org/keywords/genital-herpes","display_name":"genital herpes","score":0.7919999957084656},{"id":"https://openalex.org/keywords/primary-infection","display_name":"primary infection","score":0.5860000252723694},{"id":"https://openalex.org/keywords/humoral-immune-response","display_name":"humoral immune response","score":0.9340000152587891},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8029999732971191},{"id":"https://openalex.org/keywords/hsv-type-2","display_name":"HSV type 2","score":0.8069999814033508},{"id":"https://openalex.org/keywords/hsv-type-1","display_name":"HSV type 1","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6334775686264038},{"id":"https://openalex.org/C2778498788","wikidata":"https://www.wikidata.org/wiki/Q7476596","display_name":"Genital herpes","level":4,"score":0.547287106513977},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.46348291635513306},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4439719021320343},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.30255305767059326},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2453363537788391}],"mesh":[{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006558","descriptor_name":"Herpes Genitalis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006558","descriptor_name":"Herpes Genitalis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018139","descriptor_name":"Simplexvirus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/infdis/150.1.7","doi":"https://doi.org/10.1093/infdis/150.1.7","is_oa":false,"landing_page_url":"https://doi.org/10.1093/infdis/150.1.7","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:6086772","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6086772","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of infectious diseases","raw_type":"Clinical Trial"},{"id":"pmh:oai:open-archive.highwire.org:jinfdis:150/1/7","doi":null,"is_oa":false,"landing_page_url":"http://jid.oxfordjournals.org/cgi/content/short/150/1/7","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W133679353","https://openalex.org/W1851353227","https://openalex.org/W1875514548","https://openalex.org/W1937493051","https://openalex.org/W1981516375","https://openalex.org/W1992062386","https://openalex.org/W2003924464","https://openalex.org/W2034160182","https://openalex.org/W2057645240","https://openalex.org/W2060631405","https://openalex.org/W2084968856","https://openalex.org/W2100837269","https://openalex.org/W2101108802","https://openalex.org/W2119867364","https://openalex.org/W2128530268","https://openalex.org/W2135686873","https://openalex.org/W2158843730","https://openalex.org/W2166828854","https://openalex.org/W2338896046"],"related_works":["https://openalex.org/W1984069441","https://openalex.org/W2049132956","https://openalex.org/W2061099857","https://openalex.org/W1968761052","https://openalex.org/W2168917201","https://openalex.org/W2019934779","https://openalex.org/W2055511505","https://openalex.org/W2043658782","https://openalex.org/W4391115541","https://openalex.org/W2040220103"],"abstract_inverted_index":{"The":[0],"humoral":[1,86],"response":[2,46,87],"to":[3,47,64,89,99,119],"herpes":[4],"simplex":[5],"virus":[6],"(HSV)":[7],"was":[8],"examined":[9],"in":[10,20],"21":[11],"patients":[12,61],"with":[13,82,104,115],"primary":[14],"HSV":[15,51,59,65],"infection":[16],"who":[17],"were":[18,56],"participating":[19],"a":[21,38,110],"placebo-controlled":[22],"trial":[23],"of":[24,50,72,107,121,126],"oral":[25],"acyclovir":[26,83],"as":[27,91],"therapy":[28],"for":[29],"first-episode":[30],"genital":[31],"herpes.":[32],"A":[33],"standard":[34],"microneutralization":[35],"assay":[36],"and":[37,54,78,98,124],"western":[39],"blot":[40],"analysis,":[41],"which":[42],"detects":[43],"the":[44,85,94],"antibody":[45],"individual":[48],"polypeptides":[49,67,114],"types":[52],"1":[53],"2,":[55],"used.":[57],"Placebo-treated,":[58],"type-2-infected":[60],"typically":[62],"responded":[63],"type-2":[66],"that":[68,112],"had":[69],"molecular":[70,105,116],"masses":[71,106,117],"125,":[73],"84,":[74],"68,":[75],"59,":[76],"46,":[77],"40":[79],"kilodaltons.":[80],"Treatment":[81],"diminished":[84],"both":[88],"HSV,":[90],"measured":[92],"by":[93],"type-specific":[95],"neutralizing-antibody":[96],"titer,":[97],"specific":[100],"polypeptides,":[101],"especially":[102],"those":[103,120],"50-100":[108],"kilodaltons,":[109],"range":[111],"includes":[113],"corresponding":[118],"glycoproteins":[122],"D":[123],"E":[125],"HSV.":[127]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005237889","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
